This section of the FEDERAL REGISTER

contains documents other than rules or

proposed rules that are applicable to the

public. Notices of hearings and investigations,

committee meetings, agency decisions and

rulings, delegations of authority, filing of

petitions and applications and agency

statements of organization and functions are

examples of documents appearing in this

section.

Notices Federal Register

105535 

Vol. 89, No. 248 

Friday, December 27, 2024 

AGENCY FOR INTERNATIONAL 

DEVELOPMENT 

Proposed Revision of AID 114–2 AntiHarassment Intake Summary Sheet 

AGENCY: United States Agency for 

International Development. 

ACTION: Notice of information collection; 

request for comment. 

SUMMARY: The United States Agency for 

International Development (USAID), in 

accordance with the Paperwork 

Reduction Act (PRA) of 1995, as 

amended, invites the general public and 

other Federal agencies to comment on 

proposed, and continuing information 

collections, which helps us assess the 

impact of our information collection 

requirements and minimize the public’s 

reporting burden. The purpose of this 

notice is to allow for 30 days of public 

comment on the AID 114–2 AntiHarassment Program Intake Summary 

Sheet, prior to the submission of the 

information collection request (ICR) to 

OMB for approval. 

DATES: All comments should be 

submitted within 30 calendar days from 

the date of this publication. 

Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

ADDRESSES: Interested persons are 

invited to submit written comments by 

email to OCRharassment@usaid.gov. 

Please reference the AID 114–2 AntiHarassment Program Intake Summary 

Sheet in the subject line of your 

comments. All comments received are 

part of the public record. No comments 

will be posted to https://

www.regulations.gov for public viewing 

until after the comment period has 

closed. Comments will generally be 

posted without change. All Personally 

Identifiable Information (for example, 

name and address) voluntarily 

submitted by the commenter may be 

publicly accessible. Do not submit 

Confidential Business Information or 

otherwise sensitive or protected 

information. You may submit 

attachments to electronic comments in 

Microsoft Word, Excel, or Adobe PDF 

file formats. 

FOR FURTHER INFORMATION CONTACT: 

Tanya Shorter, Lead Anti-Harassment 

Program Specialist, USAID, Office of 

Civil Rights, telephone 771–202–3478 or 

email at OCRharassment@usaid.gov. 

SUPPLEMENTARY INFORMATION: The 

purpose of the AID 114–2 form is to 

document basic information regarding 

allegations of harassment to include the 

following: Information about involved 

individuals, including the individual 

alleged to be harassed, the alleged 

harasser, and witnesses or others with 

knowledge of the incident(s): (1) full 

name, (2) contact information, (3) 

position title, (4) hiring mechanism, and 

(5) office/work location; (6) Description 

of the alleged harassment, including the 

date(s) the alleged harassment occurred 

and whether the alleged harassment is 

alleged to be based on a protected EEO 

category (race, color, national origin, sex 

(including pregnancy, gender identity, 

sexual orientation, or transgender 

status), age (40 or older), religion, 

genetic information (including family 

medical history), physical or mental 

disability, or retaliation); (7) Whether 

the supervisor and/or other management 

official took any steps in response to the 

alleged harassment; and (8) Any other 

useful, preliminary information. 

Type of Information Collection: AID 

114–2 Anti-Harassment Program Intake 

Summary Sheet. 

Type of Request: Notice for public 

comment. 

Originating Office: USAID’s Office of 

Civil Rights. 

Respondents: General public and 

other Federal agencies. 

Respondent’s obligation to respond: 

Voluntary. 

Estimated number of respondents: 

400. 

Average time per response: 15 

minutes for respondents. 

Frequency of response: Once. 

Total estimated burden: 100. 

Total estimated burden cost: None. 

We are soliciting general public and 

other federal agencies comments to 

permit USAID to: 

• Evaluate whether the proposed 

information collection is necessary for 

the proper functions of USAID. 

• Enhance the quality, utility, and 

clarity of the information to be 

collected. 

• Minimize the reporting burden on 

those who are to respond. 

Stephen Shih, 

Director, Office of Civil Rights, U.S. Agency 

for International Development. 

[FR Doc. 2024–30954 Filed 12–26–24; 8:45 am] 

BILLING CODE 6116–01–P 

DEPARTMENT OF COMMERCE 

National Institute of Standards and 

Technology 

Dietary Supplement Laboratory Quality 

Assurance Program (DSQAP) 

Consortium 

AGENCY: National Institute of Standards 

and Technology, Department of 

Commerce. 

ACTION: Notice of research consortium. 

SUMMARY: The National Institute of 

Standards and Technology (NIST), an 

agency of the United States Department 

of Commerce, in support of efforts to 

develop and evaluate measurement 

methods and standards, including 

reference materials, to support quality 

and safety for the dietary supplement 

testing community, is establishing the 

Dietary Supplement Laboratory Quality 

Assurance Program (DSQAP) 

Consortium (‘‘Consortium’’). The 

Consortium will bring together 

stakeholders to identify and address 

measurement and standards needs 

related to analytical testing of dietary 

supplement ingredients and products. 

The Consortium efforts are intended to 

advance measurement capabilities, 

provide measurement quality assurance 

strategies, support the development of 

dietary supplement reference materials, 

and collect data to support the 

development of best practices and 

standard methods. Participants will be 

required to sign a Cooperative Research 

and Development Agreement (CRADA). 

At NIST’s discretion, entities that are 

not permitted to enter into CRADAs 

pursuant to law or other governmental 


khammond on DSK9W7S144PROD with NOTICES
105536 Federal Register / Vol. 89, No. 248 / Friday, December 27, 2024 / Notices 

constraint may be allowed to participate 

in the Consortium pursuant to a 

separate non-CRADA agreement. 

DATES: The Consortium’s activities will 

commence on May 1, 2025 

(‘‘Commencement Date’’). NIST will 

accept letters of interest to participate in 

this Consortium on an ongoing basis. 

ADDRESSES: Completed letters of interest 

must be submitted via the letter of 

interest webform at https://forms.gle/ 

bCMV9tmc9uRyZxmRA, by email to 

melissa.phillips@nist.gov, or via 

hardcopy to the Consortium Manager, 

Dr. Melissa Phillips, Chemical Sciences 

Division of NIST’s Material 

Measurement Laboratory, 100 Bureau 

Drive, Mail Stop 8390, Gaithersburg, 

Maryland 20899. Organizations whose 

letters of interest are accepted in 

accordance with the process set forth in 

the SUPPLEMENTARY INFORMATION section 

of this notice will be asked to sign a 

consortium CRADA with NIST. A 

consortium CRADA template will be 

made available to qualifying applicants. 

FOR FURTHER INFORMATION CONTACT: 

J’aime Maynard, Consortia Agreements 

Officer, National Institute of Standards 

and Technology’s Technology 

Partnerships Office, by mail to 100 

Bureau Drive, Mail Stop 2200, 

Gaithersburg, Maryland 20899, by 

electronic mail agreements@nist.gov, or 

by phone (301) 975–8408. 

SUPPLEMENTARY INFORMATION: The 

objective of the DSQAP is to develop 

and evaluate measurement methods and 

standards to support quality and safety 

for the dietary supplement testing 

community. Approximately 75% of the 

U.S. population takes dietary 

supplements, including vitamins and 

mineral supplements, representing an 

annual expenditure of more than $20 

billion USD. Regulations, driven by 

reported cases of inaccurate labeling, 

adulteration, contamination (with 

pesticides, heavy metals, or toxic 

botanicals), and drug interactions, are 

now in place that require manufacturers 

to evaluate the identity, purity, and 

composition of their ingredients and 

finished products. The plethora of 

unique products on the market has led 

to an uptick in published methods but 

limited outlets for external method 

evaluation and validation. 

The focus of this Consortium is to 

evaluate and standardize methods to 

characterize and quantify nutrients, 

marker compounds, and/or 

contaminants in dietary supplement 

ingredients and finished products, 

improving overall comparability within 

the community and enabling 

organizations that join the Consortium 

(‘‘Consortium Members’’) to improve the 

accuracy and precision of their own, 

internal measurements. The Consortium 

will organize at least two interlaboratory 

exercises annually based on candidate 

reference materials and/or commercial 

products with the following goals: 

• Evaluate the suitability of current 

published methods, including standard 

methods, to measure nutrients, marker 

compounds, and/or contaminants in 

dietary supplement ingredients and 

finished products. 

• Utilize common materials to collect 

reproducibility data in support of 

measurement assurance and standards 

development. 

• Propose tests(s) that can be 

standardized through the AOAC 

International or similar consensus 

process, using outcomes from 

Consortium efforts as a foundation. 

• Evaluate the applicability of current 

reference materials for dietary 

supplement ingredient and finished 

product testing. If needed, develop new 

reference materials to support 

advancement of the dietary supplement 

testing industry. 

No proprietary information will be 

shared as part of the Consortium. 

Contributions of materials to be used as 

interlaboratory study samples, such as 

dietary supplement ingredients or 

products, are highly encouraged. 

Participation Process 

Eligibility to participate in the 

Consortium will be determined by NIST 

based on the information provided by 

prospective participants in response to 

this notice. Prospective participants can 

submit a letter of interest by completing 

the letter of interest webform at https:// 

forms.gle/bCMV9tmc9uRyZxmRA; 

alternatively, parties can answer the 

questions detailed in LETTER OF 

INTEREST, below, and send via email 

or hardcopy (for reference, see 

ADDRESSES section above). NIST will 

contact interested parties if there are 

questions regarding the responsiveness 

of the letters of interest to the project 

objective or requirements identified 

below. 

Each responding organization’s letter 

of interest should include the address, 

point of contact, and following 

information: 

(1) The contribution(s) the 

organization will make to the 

Consortium efforts. All Consortium 

members must contribute one or more of 

the following: 

a. Analytical Testing: Narrative of 

interest and experience in analytical 

testing of dietary supplement 

ingredients and products and 

description of the services and/or 

technical capabilities (e.g., available 

instrumentation, relevant accreditations, 

published methods) they will contribute 

to Consortium activities. 

b. Materials: Narrative of interest and 

description of the dietary supplement 

ingredients and products they will 

contribute to Consortium activities. 

c. Unique Industry or Community 

Perspective: Narrative of interest and 

description of other relevant expertise 

(e.g., trade associations, regulatory 

oversight, standards development) they 

will contribute to Consortium activities. 

(2) List of anticipated participating 

individuals. 

Letters of interest must not include 

proprietary information, including 

proprietary business information. NIST 

will not treat any information provided 

in response to this notice as proprietary 

information. NIST will notify each 

organization of its eligibility to join the 

Consortium. In order to participate in 

this Consortium, each eligible 

organization must sign a CRADA. 

Entities that are not permitted to enter 

into CRADAs pursuant to law or other 

governmental constraint may be allowed 

to participate in the Consortium, at 

NIST’s discretion, pursuant to separate 

non-CRADA agreements with terms that 

may differ, as necessary from the 

Consortium CRADA terms. NIST does 

not guarantee participation in the 

Consortium to any organization 

submitting a letter of interest. 

Authority: 15 U.S.C. 3710a. 

Alicia Chambers, 

NIST Executive Secretariat. 

[FR Doc. 2024–30948 Filed 12–26–24; 8:45 am] 

BILLING CODE 3510–13–P 

DEPARTMENT OF COMMERCE 

National Oceanic and Atmospheric 

Administration 

[RTID 0648–XE504] 

Taking and Importing Marine 

Mammals; Taking Marine Mammals 

Incidental to Geophysical Surveys 

Related to Oil and Gas Activities in the 

Gulf of Mexico 

AGENCY: National Marine Fisheries 

Service (NMFS), National Oceanic and 

Atmospheric Administration (NOAA), 

Commerce. 

ACTION: Notice of issuance of letter of 

authorization. 

SUMMARY: In accordance with the 

Marine Mammal Protection Act 

(MMPA), as amended, its implementing 

regulations, and NMFS’ MMPA 

Regulations for Taking Marine 

Mammals Incidental to Geophysical 


khammond on DSK9W7S144PROD with NOTICES